Identification of CXCL5 expression as a predictive biomarker associated with response and prognosis of immunotherapy in patients with non‐small cell lung cancer

BACKGROUND: The breakthrough of immunotherapy has revolutionized the treatment of non‐small cell lung cancer (NSCLC). However, only a limited part of patients could derive clinical benefits. To study how immune microenvironment (IME) of patients could influence the therapeutic efficacy of immunother...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Jie, Ma, Xuejiao, Ni, Yang, Li, Xiaomin, Xi, Wenjing, Tian, Minqi, Zhang, Xing, Xiang, Manyu, Deng, Wanglong, Song, Chao, Wu, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9041069/
https://www.ncbi.nlm.nih.gov/pubmed/35150082
http://dx.doi.org/10.1002/cam4.4567

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9041069/
https://www.ncbi.nlm.nih.gov/pubmed/35150082
http://dx.doi.org/10.1002/cam4.4567

Ejemplares similares